1. Home
  2. SPNS vs CGON Comparison

SPNS vs CGON Comparison

Compare SPNS & CGON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPNS
  • CGON
  • Stock Information
  • Founded
  • SPNS 1982
  • CGON 2010
  • Country
  • SPNS Israel
  • CGON United States
  • Employees
  • SPNS N/A
  • CGON N/A
  • Industry
  • SPNS Computer Software: Prepackaged Software
  • CGON
  • Sector
  • SPNS Technology
  • CGON
  • Exchange
  • SPNS Nasdaq
  • CGON NYSE
  • Market Cap
  • SPNS 1.5B
  • CGON 1.3B
  • IPO Year
  • SPNS 1992
  • CGON 2024
  • Fundamental
  • Price
  • SPNS $28.70
  • CGON $25.62
  • Analyst Decision
  • SPNS Buy
  • CGON Strong Buy
  • Analyst Count
  • SPNS 4
  • CGON 10
  • Target Price
  • SPNS $34.25
  • CGON $64.00
  • AVG Volume (30 Days)
  • SPNS 188.2K
  • CGON 1.4M
  • Earning Date
  • SPNS 05-08-2025
  • CGON 05-13-2025
  • Dividend Yield
  • SPNS 3.31%
  • CGON N/A
  • EPS Growth
  • SPNS 11.11
  • CGON N/A
  • EPS
  • SPNS 1.30
  • CGON N/A
  • Revenue
  • SPNS $544,235,000.00
  • CGON $662,000.00
  • Revenue This Year
  • SPNS $7.54
  • CGON N/A
  • Revenue Next Year
  • SPNS $6.90
  • CGON $12,387.03
  • P/E Ratio
  • SPNS $22.08
  • CGON N/A
  • Revenue Growth
  • SPNS 3.84
  • CGON 224.51
  • 52 Week Low
  • SPNS $23.69
  • CGON $14.80
  • 52 Week High
  • SPNS $41.22
  • CGON $40.47
  • Technical
  • Relative Strength Index (RSI)
  • SPNS 60.01
  • CGON 53.27
  • Support Level
  • SPNS $27.36
  • CGON $24.79
  • Resistance Level
  • SPNS $28.84
  • CGON $26.60
  • Average True Range (ATR)
  • SPNS 0.53
  • CGON 1.39
  • MACD
  • SPNS -0.02
  • CGON -0.01
  • Stochastic Oscillator
  • SPNS 79.76
  • CGON 48.52

About SPNS Sapiens International Corporation N.V. (Cayman Islands)

Sapiens International Corp NV is a provider of software solutions for the insurance industry, with an emerging focus on the financial services sector. The company offers software, solutions, and professional services for property & casualty (P&C); reinsurance; life, pension & annuity (L&A); workers' compensation (WC); medical professional liability (MPL); financial & compliance (F&C); and decision modeling for both insurance and financial markets. The group also provides services for project delivery and implementation services, for its Software Solutions portfolio. Geographically, it operates in the region of North America, Rest of the World, and Europe. It generates revenue from Europe.

About CGON CG ONCOLOGY INC

CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.

Share on Social Networks: